![](https://scx1.b-cdn.net/csz/news/tmb/2021/novel-radionuclide-the.jpg)
Novel radionuclide therapy proven safe and effective to treat neuroendocrine neoplasms
A new type of peptide receptor radionuclide therapy (PRRT) has been shown to control disease in 85 percent of patients with metastatic neuroendocrine neoplasms, achieving complete remission in some patients. The first-in-human ...
Nov 23, 2021
0
7